Under the Company’s Employee Stock Option Plan, as amended and restated as of April 4, 2013 (the “Plan”), the Compensation Committee of the Board of Directors, which consists of three of the Company’s non-employee directors, has the authority to grant participants incentive stock options, nonqualified stock options, restricted stock, stock appreciation rights and stock awards, for up to 11,000,000 shares of common stock.

Stock options granted to participants under the plan generally became exercisable in equal installments over three years or cliff-vested after three years and remain exercisable until the tenth anniversary of the date of grant. All stock options granted under the Plan have an exercise price equal to or greater than the fair market value of the Company’s common stock on the grant date.

The fair value of the stock options, less expected forfeitures, is amortized on a straight-line basis over the vesting term. Total compensation expense for stock option grants recognized during the three months ended April 30, 2020 and 2019 was $0.1 million (net of tax of approximately $22,000) and $0.2 million (net of tax of $0.1 million), respectively. As of April 30, 2020, all stock options have vested so, as a result, there was no unrecognized compensation cost related to unvested stock options. Total consideration received for stock option exercises during the three months ended April 30, 2020 and 2019 was zero and $0.2 million, respectively.

The following table summarizes the Company’s stock options activity during the first quarter of fiscal 2021:

	Outstanding Options		Weighted Average Exercise Price per Option		Option Price Per Share	Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value $(000)
Options outstanding at January 31, 2020 (399,905 options exercisable)		561,110	$	28.41	$23.35-$42.12	5.2	$	-
Granted		—
Exercised		—
Cancelled		—
Options outstanding at April 30, 2020		561,110	$	28.41	$23.35-$42.12	4.9	$	-
Exercisable at April 30, 2020		561,110	$	28.41		4.9	$	-

Under the Plan, the Company can also grant stock awards to employees and directors. For the three months ended April 30, 2020 and 2019, compensation expense for stock awards was $1.1 million (net of tax of $0.4 million) and $1.1 million (net of tax of $0.3 million), respectively. As of April 30, 2020, there was $6.4 million of unrecognized compensation cost related to unvested stock awards.

The following table summarizes the Company’s stock awards activity during the first quarter of fiscal 2021:

	Number of Stock Award Units			Weighted- Average Grant Date Fair Value		Weighted- Average Remaining Contractual Term (years)	Aggregate Intrinsic Value $(000's)
Units outstanding at January 31, 2020		490,239		$	33.50	1.4	$	8,442
Units granted		86,500		$	10.00
Units vested		(141,235	)	$	26.88
Units forfeited		(3,409	)	$	25.75
Units outstanding at April 30, 2020		432,095		$	31.02	1.3	$	4,455

Outstanding stock awards can be classified as either time-based stock awards or performance-based stock awards. Time-based stock awards vest over time subject to continued employment. Performance-based stock awards vest over time subject both to continued employment and to the achievement of corporate financial performance goals. Upon the vesting of a stock award, shares are issued from the pool of authorized shares. For performance-based stock awards, the number of shares issued related to the performance units granted can vary from 0% to 150% of the target number of underlying stock award units, depending on the extent of the achievement of predetermined financial goals. The total fair value of stock award units that vested during the first three months of fiscal 2021 was $3.8 million. The number of shares issued related to the remaining stock awards are established at grant date.